✦ LIBER ✦

810 ORAL Risk and risk factors of renal impairment in hormone refractory prostate cancer (HPRC) patients with bone metastases (BM) treated with Zoledronic Acid (ZA)

Book ID: 118623386
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 429 KB
Volume: 3
Category: Article
ISSN: 1359-6349
DOI: 10.1016/s1359-6349(05)81105-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The risk of renal impairment in hormone-

The risk of renal impairment in hormone-refractory prostate cancer patients with bone metastases treated with zoledronic acid

✍ William K. Oh; Kevin Proctor; Mari Nakabayashi; Carolyn Evan; Lauren K. Tormey; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB 👁 2 views

CO4 A COMPARISON OF LOGISTIC REGRESSION

CO4 A COMPARISON OF LOGISTIC REGRESSION AND COX PROPORTIONAL HAZARDS MODELS FOR IDENTIFICATION OF RISK FACTORS FOR RENAL IMPAIRMENT IN HORMONE REFRACTORY PROSTATE CANCER (HRPC) PATIENTS WITH BONE METASTASES (BM) TREATED WITH ZOLEDRONIC ACID (ZA)

✍ WK Oh; K Proctor; M Nakabayashi; C Evan; LK Tormey; L Breierova; M Smith; M Near 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

176 NUMBER NEEDED TO TREAT AND RISK BENE

176 NUMBER NEEDED TO TREAT AND RISK BENEFIT ANALYSIS OF DENOSUMAB VERSUS ZOLEDRONIC ACID IN THE TREATMENT OF CASTRATE-RESISTANT PROSTATE CANCER PATIENTS WITH BONE METASTASES

✍ Xie, Jipan; Diener, Melissa; Wu, Eric; Sorg, Rachael; Yu, Andrew; Namjoshi, Madh 📂 Article 📅 2012 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 47 KB